The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Predicine
Predictive value of germline ATM mutations in the CCTG PA.7 trial: Gemcitabine (GEM) and nab-paclitaxel (Nab-P) versus GEM, nab-P, durvalumab (D) and tremelimumab (T) as first-line therapy in metastatic pancreatic ductal adenocarcinoma (mPDAC).
 
Daniel John Renouf
Honoraria - Celgene; Ipsen; Roche; SERVIER; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Celgene; SERVIER; Shire; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Bayer (Inst)
 
Jonathan M. Loree
Consulting or Advisory Role - AMGEN; Bayer; Eisai; Ipsen; Novartis; Pfizer; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Ipsen (Inst)
 
Jennifer J. Knox
Honoraria - Novartis; Roche Canada
Consulting or Advisory Role - AstraZeneca/MedImmune; Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca
 
Petr Kavan
Stock and Other Ownership Interests - Bristol-Myers Squibb; Teva
Honoraria - Amgen
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Merck; Novartis; Pfizer; Roche Canada; Taiho Pharmaceutical
Research Funding - Amgen (Inst)
 
Derek J. Jonker
No Relationships to Disclose
 
Stephen Welch
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Pfizer; Roche Canada
Consulting or Advisory Role - Amgen; Eisai
 
Felix Couture
Consulting or Advisory Role - Bristol-Myers Squibb
 
Frederic Lemay
Leadership - AurKa Pharma; Esperas Pharma; Ocellaris Pharma
Honoraria - AurKa Pharma; Esperas Pharma; Ocellaris Pharma
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Esperas Pharma; Merck; Pfizer; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Taiho Pharmaceutical; Taiho Pharmaceutical
 
Mustapha Tehfe
Honoraria - Bristol-Myers Squibb; Celgene; Eisai; Merck; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Merck; Taiho Pharmaceutical; Takeda
Speakers' Bureau - Celgene
Research Funding - Celgene
 
Mohammed Harb
No Relationships to Disclose
 
Nathalie Aucoin
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Ipsen; Merck; Novartis; Pfizer; Roche Canada
Research Funding - AstraZeneca (Inst); Merck (Inst)
 
Yoo-Joung Ko
No Relationships to Disclose
 
Patricia A. Tang
Consulting or Advisory Role - AMGEN; AstraZeneca; AstraZeneca; Celgene; Eisai; Eisai; Genomic Health International; Merck; Pfizer; Pfizer; Taiho Pharmaceutical; Teva
Travel, Accommodations, Expenses - Amgen
Other Relationship - Novartis
 
James T. Topham
No Relationships to Disclose
 
Shidong Jia
No Relationships to Disclose
 
Pan Du
Employment - Predicine
 
David F. Schaeffer
Stock and Other Ownership Interests - Satisfai Health
Honoraria - Alimentiv; Diaceutics; Merck; Pfizer
 
Sharlene Gill
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Ipsen; Roche Canada; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical (Inst)
 
Dongsheng Tu
No Relationships to Disclose
 
Christopher J. O'Callaghan
No Relationships to Disclose